ORLANDO, Fla. – Clinicians should consider rosacea in patients with meibomian gland dysfunction, according to a speaker here at the American Academy of Optometry meeting.

The OCEAN group (Geerling et al.) showed that 90% of patients with ocular rosacea have eyelid changes similar to those observed in patients with meibomian gland dysfunction (MGD), Kelly K. Nichols, OD, MPH, PhD, FAAO, said during the Anterior Segment Section Symposium, which was sponsored by Primary Care Optometry News.